Rodent Carcinogenicity of Peroxisome Proliferators and Issues on Human Relevance

References

• Stott , WT . 1988 . Chemically induced proliferation of peroxisome: implications for risk assessment . Regul Toxicol Pharmacol , 8 : 125 – 159 . [CSA]
   PubMed Web of Science ®Google Scholar
• Bentley , P , Calder , I , Elcombe , C , Grasso , P , Stringer , D and Wiegand , H-J . 1993 . Hepatic peroxisome proliferation in rodents and its significance for humans . Fd Chem Tox , 31 : 857 – 907 . [CSA]
   PubMed Web of Science ®Google Scholar
• Lake , BG , Evans , JG , Gray , TJB , Korosi , SA and North , CJ . 1989 . Comparative studies on nafenopin-induced hepatic peroxisome proliferation in the rat, Syrian hamster, guinea pig, and marmoset . Toxicol Appl Pharmacol , 99 : 148
   PubMed Web of Science ®Google Scholar
• Lake , BG , Rumsby , PC , Price , RJ and Cunningham , ME . 2000 . Species differences in hepatic peroxisome proliferation cell replication and transforming growth factor-β-1 gene expression in the rat, Syrian hamster and guinea pig . Mutat Res , 448 ( 2 ) : 213 – 225 . [CSA]
   PubMedGoogle Scholar
• Hanefeld , M , Kemmer , C and Kadner , E . 1983 . Relationship between morphorlogical changes and lipid lowering action of p-chlorophenoxyisobutyric acid (CPIB) on hepatic mitochondria and peroxisomes in man . Atherosclerosis , 46 : 239 – 246 . [CSA]
   PubMed Web of Science ®Google Scholar
• Moody , DE , Reddy , JK , Lake , BG , Popp , JA and Reese , DH . 1991 . Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium . Fund Appl Toxicol , 16 : 233 – 248 . [CSA]
   PubMed Web of Science ®Google Scholar
• Reddy , JK and Lalwai , ND . 1983 . Carcinogenesis by hepatic peroxisome proliferators. Evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans . CRC Crit Rev Toxicol , 12 : 1 – 58 . [CSA]
   Web of Science ®Google Scholar
• Moody , DE and Reddy , JK . 1978 . Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds . Toxicol Appl Pharmacol , 45 : 497 – 504 . [CSA]
   PubMed Web of Science ®Google Scholar
• Kluwe , WM , Huff , JE , Matthews , HB , Irwin , R and Haseman , JK . 1985 . Comparative chronic toxicities and carcinogenic potentials of 2-ethylhexyl-containing compounds in rats and mice . Carcinogenesis , 6 : 1577 – 1583 . [CSA]
   PubMedGoogle Scholar
• Lington , AW , Bird , MG , Plutnick , RT , Stubblefield , WA and Scala , RA . 1997 . Chronic, toxicity and carcinogenic evaluation of diisononyl phthalate in rats . Fund Appl Toxicol , 36 : 79 – 89 . [CSA]
   PubMedGoogle Scholar
• Butala , JH , Moore , MR and Cifone , MA . 1997 . Oncogenicity study of diisononyl phthalate in mice . Toxicologist , 36 ( 1 ) : 173 [CSA]
   Google Scholar
• Astill , BD , Gingell , R , Quest , D , Hellwig , J , Hodgson , JR , Kuettler , K , Mellert , W , Murphy , SR , Sielken , RL Jr and Tyler , TR . 1996 . Oncogenicity testing of 2-ethylhexanol in Fischer 344 rats and B6C3F1 mice . Fund Appl Toxicol , 31 : 29 – 41 . [CSA]
   PubMedGoogle Scholar
• Gold , LS and Zeiger , E . 1997 . “ Handbook of Carcinogenic Potency and Genotoxicity Databases ” . New York : CRC Press .
   Google Scholar
• Malley , LA , Carakostas , M , Hansen , JF , Rusch , GM , Kelley , DP and Trochimowicz , HJ . 1995 . Two-year inhalation toxicity study in rats with hydrochorofluorocarbon 123 . Fund Appl Toxicol , 25 : 101 – 114 . [CSA]
   PubMedGoogle Scholar
• Shirasu , Y . 1987 . “ Oxadiazon—24 Month Chronic Toxicity and Carcinogenicity Study in Wistar Rats ” . Tokoyo, , Japan : Institute of Environmental Toxicology . MRID 40993401 (unpublished)
   Google Scholar
• Shirasu , Y . 1987 . “ Oxadiazon—23 Month Chronic Toxicity and Carcinogenicity Study in ICR-JCL Mice ” . Tokoyo, , Japan : Institute of Environmental Toxicology . MRID 40993301 (unpublished)
   Google Scholar
• Hollander , H and Wiegand , W . 1978 . “ Diclofop methyl-Toxicity and Tumorigenicity Study in Mice during Dietary Administration for 2 Years with Interim Sacrifice After 88 Weeks ” . Frankfurt, , Germany : Prepared by Pharma Research Toxicology and Pathology . MRID 92036058 (unpublished)
   Google Scholar
• EPA . 1981 . “ Carcinogenicity Studies of Oxadiazon in Fischer Rat. Nippon Institute for Biological Sciences, Japan (unpublished), EPA accession numbers 256142, 256143, 256144 ” . Washington, DC : Office of Pesticides Program, U.S. Environmental Protection Agency .
   Google Scholar
• EPA . 1982 . “ Carcinogenicity Studies of Oxadiazon in CD Mice; Life Sciences Research England, (unpublished). EPA accession numbers 248601, 248602, 248603, 248604, 248605 ” . Washington, DC. : Office of Pesticides Program, U.S. Environmental Protection Agency .
   Google Scholar
• EPA . 1985 . “ Lactofen—Mouse—Oncogenicity Study in Mice PPG-844 Technical. Hazelton Laboratories, Vienna, Virginia. EPA Accession No. 073848 ” . Washington, DC : Office of Pesticides Program, U.S. Environmental Protection Agency .
   Google Scholar
• EPA . 1996 . “ Diclofop Methyl—Combined Chronic Toxicity (12 and 24 Months) and Carcinogenicity (24 Months) Study in Rats. Hoechst Aktiengesellschaft, D-65926 Frankfurt am Main. Unpublished. EPA Accession No. 43927302 ” . Washington, DC : Office of Pesticides Program, U.S. Environmental Protection Agency .
   Google Scholar
• NTP . 1993 . Compendium of abstracts from long-term cancer studies reported by the National Toxicology Program from 1976–1992 . Enviorn Health Persp , 101 ( Suppl 1 ) : 1 – 295 . [CSA]
   Google Scholar
• Biegel , LB , Hurtt , ME , Frame , SR , O’Conner , JC and Cook , J . 2001 . Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats . Toxicol Sci , 60 : 44 – 55 . [CSA]
   PubMed Web of Science ®Google Scholar
• Svoboda , DJ and Azarnoff , DL . 1979 . Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolidemic drug . Cancer Res , 39 : 3419 – 3428 . [CSA]
   PubMed Web of Science ®Google Scholar
• Tucker , MJ and Orton , TC . 1995 . “ Comparative Toxicology of Hypolipidaemic Fibrates ” . Bristol, PA : Taylor and Francis .
   Google Scholar
• Reddy , JK and Rao , MS . 1997 . Transplantable pancreatic carcinoma of the rat . Science , 198 : 78 – 80 . [CSA]
   Google Scholar
• Reddy , JK and Rao , MS . 1997 . Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator . J Natl Cancer Inst , 59 : 645 – 1650 . [CSA]
   Google Scholar
• Committee of Principal Investigators . 1978 . A cooperative trial in the primary prevention of ischemic heart disease using clofibrate . Br Heart J , 40 : 1069 – 1118 . [CSA]
   PubMedGoogle Scholar
• Committee of Principal Investigators . 1980 . WHO cooperative trial on the primary prevention of ischemic heart disease using clofibrate to lower serum cholesterol: mortality follow-up . Lancet , ii : 379 – 385 . [CSA]
   Google Scholar
• Committee of Principal Investigators . 1984 . WHO cooperative trial on the primary prevention of ischemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up . Lancet , ii : 600 – 604 . [CSA]
   Google Scholar
• IARC. , International Agency for Research on Cancer . 1996 . Some pharmaceutical drugs . Clofibrate, Lyon, France , 66 : 391 – 426 . [CSA]
   Google Scholar
• Frick , MH , Elo , O , Heinonen , OP , Heinsalmi , P , Helo , P , Huttenen , JK , Kaitaniemi , P , Koskinen , P and Manninen , V . 1987 . Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary breast disease . New Engl J Med , 317 : 1237 – 1245 . [CSA]
   PubMed Web of Science ®Google Scholar
• Issemann , I and Green , S . 1990 . Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators . Nature , 347 : 645 – 650 . [CSA]
   PubMed Web of Science ®Google Scholar
• Corton , JC , Lapinskas , PJ and Gonzalez , FJ . 2000 . Central role of PPAR in the mechanism of action of hepatocarcinogenic peroxisome proliferators . Mutat Res , 448 : 139 – 151 . [CSA]
   PubMed Web of Science ®Google Scholar
• Peters , JM , Cattley , RC and Gonzalez , FJ . 1997 . Role of PPAR alpha in the mechanism of action of the nongenotoxic carcinogen and peroxisome proliferator Wy-14,643 . Carcinogenesis , 18 ( 11 ) : 2029 – 2033 . [CSA]
   PubMed Web of Science ®Google Scholar
• Marsman , DS , Cattley , RC , Conway , JG and Popp , JA . 1988 . Relationship of hepatic peroxisome proliferation and replicative DNA synthesis to the hepatocarcinogenesis of the peroxisome proliferators DEHP and Wy-14,643 in rats . Cancer Res , 48 : 6739 – 6744 . [CSA]
   PubMed Web of Science ®Google Scholar
• Lake , BG , Rumsby , PC , Price , RJ and Cunninghame , ME . 2000 . Species differences in hepatic roxisome proliferation, cell replication and transforming growth factorbeta1 gene expression in the rat, Syrian hamster and guinea pig . Mutat Res , 448 : 213 – 225 . [CSA]
   PubMedGoogle Scholar
• Rose , ML , Rusyn , I , Bojes , HK , Belyea , J , Cattley , RC and Thurman , RG . 2000 . Role of Kupffer cells and oxidants in signaling peroxisome proliferator-induced hepatocyte proliferation . Mutat Res , 448 : 179 – 192 . [CSA]
   PubMed Web of Science ®Google Scholar
• Rao , MS and Reddy , JK . 1996 . Hepatocarcinogenesis of peroxisome proliferators . Ann NY Acad Sci , 804 : 573 – 587 . [CSA]
   PubMed Web of Science ®Google Scholar
• Cattley , RC , DeLuca , J , Elcombe , C , Fenner-Crisp , P , Lake , BG , Marsman , DS , Pastoor , TA , Popp , JA , Robinson , DE , Schwetz , B , Tugwood , J and Wahli , W . 1998 . Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans? Reg . Toxicol Pharmacol , 27 : 47 – 60 . [CSA]
   Google Scholar
• Cook , JC , Murray , SM , Frame , SR and Hurtt , ME . 1992 . Induction of Leydig cell adenomas by ammonium perfluorooctanoate: a possible endocrine-related mechanism . Toxicol Appl Pharmacol , 113 : 209 – 217 . [CSA]
   PubMed Web of Science ®Google Scholar
• Obourn , JD , Frame , SR , Bell , RH Jr , Longnecker , DS , Elliott , GS and Cook , JC . 1997 . Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferators Wy-14,643 . Toxicol Appl Pharmacol , 145 : 425 – 436 . [CSA]
   PubMed Web of Science ®Google Scholar
• Dekant , W , Metzler , M and Henschler , D . 1986 . Identification of S-1,2-dichlorovinyl-N-acetylcysteine as a urinary metabolite of trichloroethylene: bioactivation through glutathione-conjugation as a possible explanation of its nephrocarcinogenicity . Biochem Pharmacol , 35 : 2455 – 2458 . [CSA]
   PubMed Web of Science ®Google Scholar
• Dekant , W , Metzler , M and Henschler , D . 1986 . Identification of S-1,2,2-trichlorovinyl-N-cetylcysteine as a urinary metabolite of tetrachloroethylene:bioactivation through glutathione-conjugation as a possible explanation of its nephro-carcinogenicity . J Biochem Toxicol , 1 : 57 – 72 . [CSA]
   PubMedGoogle Scholar
• Green , T , Odum , J , Nash , JA and Foster , JR . 1990 . Perchloroethylene-induced rat kidney tumors: an investigation of the mechanisms involved and their relevance to humans . Toxicol Appl Pharmacol , 103 : 77 – 89 . [CSA]
   PubMed Web of Science ®Google Scholar
• Ashby , J , Brady , A , Elcombe , CR , Elliott , BM , Ishmael , J , Odum , J , Tugwood , JD , Kettle , S and Purchase , IFH . 1994 . Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis . Hum Exp Toxicol , 13 ( Suppl 2 ) : S1 – S117 . [CSA]
   PubMedGoogle Scholar
• IARC. , International Agency for Research on Cancer . 2000 . Some industrial chemicals, di(2-ethylhexyl)phthalate . Lyon, France , 77 : 41 – 148 . [CSA]
   Google Scholar
• Van den Heuve , JP . 1999 . Peroxisome proliferator-activated receptor (PPARs) and carcinogenesis . Toxicol Sci , 47 : 1 – 8 . [CSA]
   PubMedGoogle Scholar
• Cohen , SM , Meek , ME , Klaunig , JE , Patton , DE and Fenner-Crisp , PA . 2003 . The human relevance of information on carcinogenic modes of action . Overview , 33 : 581 – 589 . [CSA]
   Google Scholar
• Meek , ME , Bucher , JR , Cohen , SM , Dellarco , V , Hill , RN , Lehman-McKeeman , LD , Longfellow , DG , Pastoor , T , Seed , J and Patton , DE . 2003 . A framework for human relevance analysis of information on carcinogenic modes of action . Crit Rev Toxicol , 33 : 591 – 653 . [CSA]
   PubMed Web of Science ®Google Scholar
• Klaunig , JE , Babich , MA , Baetcke , KP , Cook , JC , Corton , JC , David , RM , DeLuca , JG , Lai , DY , McKee , RH , Peters , JM , Roberts , RA and Fenner-Crisp , PA . 2003 . PPAR,agonist-induced rodent tumors: mode of action and human relevance . Crit Rev Toxicol , 33 : 655 – 780 . [CSA]
   PubMed Web of Science ®Google Scholar
• Isenberg , JS , Kamendulis , LM , Ackley , DC , Smith , JH , Pugh , G Jr , Lington , AW , McKee , RH and Klaunig , JE . 2001 . Reversibility and persistence of di-2-ethylhexyl phthalate and phenobarbital-induced hepatocellular changes in rodents . Toxicol Sci , 64 : 192 – 199 . [CSA]
   PubMed Web of Science ®Google Scholar
• PDR , Lopid . 1993 . Physician's Desk Reference 1787 – 1790 . Medical Economics Data .
   Google Scholar
• Scotto , C , Keller , J-M , Schohn , H and Dauca , M . 1995 . Comparative effects of clofibrate on peroxisomal enzymes of human (Hep EBNA2) and rat (FaO) hepatoma cell lines . Euro J Cell Biol , 66 : 375 – 381 . [CSA]
   PubMedGoogle Scholar
• Walgren , JE , Kurtz , DT and McMillan , JM . 2000 . Expression of PPAR,in human hepatocytes and activation by trichloroacetate and dichloroacetate . Res Commun Mol Pathol Pharmacol , 108 : 116 – 131 . [CSA]
   PubMed Web of Science ®Google Scholar
• Just , WW , Gorgas , K , Hartl , F-U , Heinemann , P , Salzer , M and Schimassek , H . 1989 . Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perflurocarboxylic acids in rat liver . Hepatology , 9 : 570 – 581 . [CSA]
   PubMed Web of Science ®Google Scholar
• Palmer , CNA , Hsu , M-H , Griffin , KJ , Raucy , JL and Johnson , EF . 1998 . Peroxisome proliferator-activated receptor alpha expression in human liver . Mol Pharmacol , 53 : 14 – 22 . [CSA]
   PubMed Web of Science ®Google Scholar
• Woodyatt , NJ , Lambe , KG , Myers , KA , Tugwood , JD and Roberts , RA . 1999 . The peroxisome proliferator (PP) response element upstream of the human acyl CoA oxidase gene is inactive among a sample human population: significance for species differences in response to PPs . Carcinogenesis , 20 : 369 – 372 . [CSA]
   PubMed Web of Science ®Google Scholar
• Sher , T , Yi , H-F , McBride , OW and Gonazalez , F . 1993 . c-DNA cloning, chromosomal mapping, and functional characterization of the human peroxisome proliferator-activated receptor . Biochemistry , 23 : 5598 – 5604 . [CSA]
   Google Scholar
• Mukherjee , R , Jow , L , Noonan , D and McDonnell , DP . 1994 . Human and rat peroxisome proliferator-activated receptor (PPARs) demonstrate similar tissue distribution but different responsiveness to PPAR activators . J Steroid Biochem Mol Biol , 51 : 157 – 166 . [CSA]
   PubMed Web of Science ®Google Scholar
• Pineau , T , Hudgins , WR , Liu , L , Chen , L-C , Sher , T , Gonazalez , FJ and Samid , D . 1996 . Activation of a human peroxisome proliferator-activated receptor by the antitumor agent phenylacetate and its analogs . Biochem Pharmacol , 52 : 659 – 667 . [CSA]
   PubMed Web of Science ®Google Scholar
• Lapinskas , PJ and Corton , JC . 1997 . Peroxisome proliferator-activated receptor alpha: central mediator of peroxisome proliferator toxicity . CIIT Activities , 17 ( 1 ) : 1 – 7 . [CSA]
   Google Scholar